Clinical Trials Directory

Trials / Completed

CompletedNCT01030991

Classification of Heart Failure With Preserved Ejection Fraction

Etiologic, Pathophysiologic, and Genetic Classification of Heart Failure With Preserved Ejection Fraction

Status
Completed
Phase
Study type
Observational
Enrollment
514 (actual)
Sponsor
Northwestern University · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to create a classification system for the heterogenous disorder of heart failure with preserved ejection fraction (HFpEF).

Detailed description

Patients with HFpEF are a heterogeneous group with varying etiology and pathophysiology, which may play a large role in the difficulty in managing these patients and enrolling them in clinical trials. A major advance in the care of patients with HFpEF would be a classification system based on etiology, pathophysiology, and/or genetic factors as well as machine learning analyses. The ultimate goal of this study is to demonstrate that it is possible to better classify patients with HFpEF based on etiologic, pathophysiologic, and genetic differences between patients. If successful, this study could lead to: (1) novel risk estimation in patients with HFpEF and (2) more fruitful clinical trials based on targeting specific subsets of HFpEF.

Conditions

Timeline

Start date
2008-07-01
Primary completion
2019-05-21
Completion
2019-05-21
First posted
2009-12-14
Last updated
2019-05-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01030991. Inclusion in this directory is not an endorsement.